ABSI Absci Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: ABSI

Price (delayed)

$4.455

Market cap

$502.46M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.2

Enterprise value

$429.86M

Highlights
ABSI's debt is down by 31% year-on-year and by 10% since the previous quarter
The equity has contracted by 36% YoY and by 10% from the previous quarter
The quick ratio has contracted by 34% YoY and by 16% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Peers: OMER OMGA

Key stats

What are the main financial stats of ABSI
Market
Shares outstanding
112.78M
Market cap
$502.46M
Enterprise value
$429.86M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.35
Price to sales (P/S)
71.7
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
75.18
Earnings
Revenue
$5.72M
EBIT
-$109.46M
EBITDA
-$95.46M
Free cash flow
-$65.24M
Per share
EPS
-$1.2
Free cash flow per share
-$0.71
Book value per share
$1.9
Revenue per share
$0.06
TBVPS
$1.84
Balance sheet
Total assets
$217.3M
Total liabilities
$41.12M
Debt
$15.96M
Equity
$176.18M
Working capital
$91.02M
Liquidity
Debt to equity
0.09
Current ratio
4.08
Quick ratio
3.93
Net debt/EBITDA
0.76
Margins
EBITDA margin
-1,669.4%
Gross margin
100%
Net margin
-1,933.6%
Operating margin
-2,020.2%
Efficiency
Return on assets
-44.1%
Return on equity
-52.5%
Return on invested capital
-92.9%
Return on capital employed
-58.3%
Return on sales
-1,914.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ABSI stock price

How has the Absci stock price performed over time
Intraday
-1.66%
1 week
-10.36%
1 month
-11.96%
1 year
221.66%
YTD
6.07%
QTD
-21.57%

Financial performance

How have Absci's revenue and profit performed over time
Revenue
$5.72M
Gross profit
$5.72M
Operating income
-$115.52M
Net income
-$110.57M
Gross margin
100%
Net margin
-1,933.6%
ABSI's net margin is down by 26% since the previous quarter and by 6% year-on-year
ABSI's operating margin is down by 25% QoQ and by 9% YoY
The gross profit has declined by 18% since the previous quarter
Absci's revenue has decreased by 18% from the previous quarter

Growth

What is Absci's growth rate over time

Valuation

What is Absci stock price valuation
P/E
N/A
P/B
2.35
P/S
71.7
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
75.18
The EPS has decreased by 4.3% YoY and by 3.4% QoQ
ABSI's price to book (P/B) is 135% higher than its last 4 quarters average of 1.0
The equity has contracted by 36% YoY and by 10% from the previous quarter
The price to sales (P/S) is 125% higher than the last 4 quarters average of 31.8
Absci's revenue has decreased by 18% from the previous quarter

Efficiency

How efficient is Absci business performance
Absci's return on equity has shrunk by 53% YoY and by 16% QoQ
Absci's return on assets has decreased by 49% YoY and by 15% QoQ
The company's return on invested capital fell by 25% QoQ but it rose by 9% YoY
The ROS has decreased by 25% QoQ and by 5% YoY

Dividends

What is ABSI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ABSI.

Financial health

How did Absci financials performed over time
The quick ratio has contracted by 34% YoY and by 16% from the previous quarter
The current ratio has contracted by 34% YoY and by 15% from the previous quarter
ABSI's debt is 91% smaller than its equity
The equity has contracted by 36% YoY and by 10% from the previous quarter
ABSI's debt is down by 31% year-on-year and by 10% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.